Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Dec 12, 2016 $118.61 $120.36 $109.80 $115.08 14 230 249
Dec 09, 2016 $126.26 $134.06 $126.06 $132.07 2 527 553
Dec 08, 2016 $125.45 $126.69 $123.13 $126.00 1 904 143
Dec 07, 2016 $122.71 $127.00 $120.75 $125.62 2 636 512
Dec 06, 2016 $124.69 $125.55 $123.67 $124.17 1 113 348
Dec 05, 2016 $124.09 $127.55 $123.85 $124.93 2 434 467
Dec 02, 2016 $122.50 $123.45 $121.34 $122.96 1 247 037
Dec 01, 2016 $122.78 $123.49 $121.32 $122.01 1 661 989
Nov 30, 2016 $125.56 $126.21 $122.16 $122.59 1 624 536
Nov 29, 2016 $121.00 $127.55 $118.58 $125.59 3 295 481
Nov 28, 2016 $118.48 $119.95 $116.63 $119.38 1 880 453
Nov 25, 2016 $118.84 $119.04 $117.31 $118.83 472 545
Nov 23, 2016 $115.46 $119.35 $114.60 $118.92 1 650 203
Nov 22, 2016 $118.44 $118.50 $114.86 $117.02 1 697 412
Nov 21, 2016 $119.93 $120.81 $117.59 $117.68 1 642 019
Nov 18, 2016 $122.49 $124.04 $119.70 $119.85 1 521 033
Nov 17, 2016 $122.35 $123.55 $121.02 $122.97 1 924 332
Nov 16, 2016 $119.88 $123.46 $119.22 $122.51 2 879 597
Nov 15, 2016 $118.85 $120.45 $117.23 $120.36 2 119 971
Nov 14, 2016 $115.10 $122.59 $114.50 $118.89 4 026 608
Nov 11, 2016 $125.76 $126.70 $111.67 $113.62 6 451 994
Nov 10, 2016 $126.25 $128.91 $125.46 $126.88 7 396 638
Nov 09, 2016 $125.49 $138.00 $123.07 $127.16 5 968 967
Nov 08, 2016 $119.35 $119.35 $119.35 $119.35 3 884 385
Nov 07, 2016 $120.05 $120.05 $120.05 $120.05 6 151 300
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT